Crossmark

Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study

Published Online: 2021-02-05

Published Print: 2021-03

Authors

Seufert, Jochen

Pfohl, Martin

Borck, Anja

Bramlage, Peter

Siegmund, Thorsten
Funding

Funding for this research was provided by:

Sanofi-Aventis Deutschland GmbH
License Information

Text and Data Mining valid from 2021-02-05

Version of Record valid from 2021-02-05
More Information

Article History

Received: 12 November 2020

Accepted: 6 January 2021

First Online: 5 February 2021

Document is current